Raymond James double downgraded CI Financial (CIXXF) to Underperform from Outperform with a C$32 price target The firm cites the diminishing ...

CI Financial Corp. (TSE:CIX – Get Free Report) has been assigned an average rating of “Hold” from the eight analysts that are ...

James made a significant adjustment to its view on CI Financial Corp . (TSX:CIX:CN) (OTC: CIFAF), shifting the stock's rating ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In the regional equity space in 2025 CI Capital, the Egypt-based brokerage, and financial services firm, favours Saudi Arabia ...

Tigran Gambaryan's journey from the IRS to Binance showcases resilience and integrity, shaping compliance in the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than ...

International credit rating agency Capital Intelligence (CI) has affirmed the long-term foreign and local currency rating (LT ...

Elevance Health's financial outlook for FY 2025 anticipates GAAP diluted earnings per share (EPS) to be in the range of $30.40 to $31.10 and adjusted diluted EPS to be in the range of $34.15 to $34.85 ...

ImmunityBio has a promising cancer treatment, Anktiva. We warn of financial risks and lack of transparency for retail investors. See more on IBRX stock here.